2025 Achievements: Investigator-Initiated Clinical Studies with Digital Tools
The first edition of the course “Estudos Clínicos de Iniciativa do Investigador com Ferramentas Digitais” (Investigator-Initiated Clinical Studies with Digital Tools) was successfully concluded in December 2025. Running from November 3rd to December 11th, the program provided an in-depth look at the implementation and management of clinical studies.
The course was a significant collaborative effort, bringing together […]
Results from the F-CHECK Study Published in Biomedicines Journal
The results of the multicenter national study F-CHECK have been published in the journal Biomedicines, highlighting the importance of screening for Fabry disease (FD) in specific cardiology patients: https://www.mdpi.com/2227-9059/13/10/2530.
The research focused on screening patients diagnosed with unexplained cardiomyopathies, including idiopathic hypertrophic cardiomyopathy (HCM), left ventricular hypertrophy, dilated-phase HCM, and dilated cardiomyopathy with late gadolinium […]
1st Meeting of the PtCRIN CTU Network
On September 29, CRU-RISE (Clinical Research Unit — RISE) participated in a strategic meeting of the PtCRIN Clinical Trial Units (CTUs) Network at ULS Coimbra.
The event brought together key national CTUs to strengthen cooperation, define new strategic goals, and foster synergies. The primary aims were to enhance the network’s impact on the national clinical research landscape and […]
Preliminary Data from F-CHECK Study Presented at ESC 2025
Preliminary results from the national F-CHECK study, unveiled at the European Society of Cardiology Congress (ESC 2025), suggest that Fabry disease may be more common among Portuguese patients with unexplained heart conditions than previously thought.
The study screened patients with idiopathic hypertrophic cardiomyopathy and left ventricular hypertrophy, revealing that many cases remain undetected. […]
